Clinical Trial Update: Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing a single dose of zoledronic acid to prevent cancer therapy-induced bone loss in breast cancer patients has completed, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-04-24